Core Viewpoint - The research highlights the mitochondrial origins of sleep pressure, suggesting that sleep is not merely a resting state for the brain but a crucial maintenance process for the body's energy supply system [4][11]. Group 1: Research Findings - A study published in Nature reveals that sleep pressure arises from ATP surplus in specific brain cells, indicating a physical basis for sleep drive [4]. - The research team conducted a comparative analysis of the single-cell transcriptome characteristics of fruit flies under sufficient sleep and sleep deprivation, finding significant gene expression changes related to mitochondrial respiration and ATP synthesis in sleep-deprived flies [6][11]. - Mitochondrial fragmentation and increased mitochondrial-autophagy were observed in affected neurons, which could be reversed by restoring sleep [6][9]. Group 2: Mechanisms of Sleep Regulation - The study found that mitochondrial dynamics (fusion and fission) significantly influence the excitability of sleep-regulating neurons, thereby affecting sleep demand [9][11]. - During wakefulness, especially under sleep deprivation, the activity of these neurons is suppressed, leading to increased ATP concentration due to reduced consumption [9]. - Manipulating mitochondrial dynamics can either enhance or reduce sleep duration, indicating a direct link between mitochondrial function and sleep regulation [9][11]. Group 3: Implications and Future Directions - The findings provide insights into the relationship between metabolism, sleep, and lifespan, suggesting that sleep may be an unavoidable byproduct of aerobic metabolism, similar to aging [10][11]. - The research opens new avenues for understanding sleep disorders and their potential interventions by targeting mitochondrial function in specific neurons [11].

Core Viewpoint - Lack of physical activity poses a significant threat to public health, increasing the incidence and mortality rates of non-communicable diseases (NCDs) globally. Exercise is recognized as the most effective and cost-efficient intervention to promote overall health and reduce the burden of NCDs. However, recent estimates indicate that 1.4 billion adults (27.5% of the global adult population) fail to meet recommended physical activity levels, with a concerning 81% of children and adolescents aged 11-17 also not meeting these levels [3][4]. Group 1 - Early-life exercise has been shown to extend healthspan but not lifespan in mice, with significant long-term health benefits observed from just three months of exercise during early life [4][6]. - The study highlights that early physical activity correlates positively with enhanced aerobic fitness, increased bone mineral density (BMD), and reduced risks of obesity, hypertension, type 2 diabetes, and heart disease in adulthood [6][7]. - The research indicates that early-life exercise leads to improved overall health in aging mice, enhancing metabolic function, cardiovascular health, and muscle strength while reducing inflammation and frailty [7][9]. Group 2 - The findings emphasize the importance of early-life physical activity interventions to optimize long-term health outcomes, suggesting that enhanced fatty acid metabolism in skeletal muscle may be a key mechanism behind these health benefits [9][10]. - Future research is necessary to explore the mechanisms by which early-life exercise impacts long-term health and to apply these findings to human populations [9].

Core Viewpoint - The study highlights the effectiveness of sequential treatment with PARP inhibitors (PARPi) followed by WEE1 inhibitors (WEE1i) in enhancing antitumor immune responses in ovarian cancer models, compared to single or combined therapies [3][4][6][7]. Group 1: Treatment Efficacy - Sequential treatment with PARPi followed by WEE1i is more effective in eradicating cancer and inducing stronger antitumor immune responses than monotherapy or combination therapy [4][6]. - Both sequential and simultaneous treatment regimens induce lethal DNA damage in cancer cells and activate the cGAS-STING pathway, but sequential treatment results in higher T cell survival rates [6][7]. Group 2: Mechanism of Action - PARP is a multifunctional enzyme that acts as a sensor for DNA damage and plays a crucial role in DNA repair [6]. - The study found that T cells recover from DNA damage faster than cancer cells after DDRi treatment, indicating a potential advantage for sequential therapy [6][7]. Group 3: Clinical Implications - In preclinical models of high-grade serous ovarian cancer and treatment-resistant ovarian cancer, the combination of immune checkpoint inhibitors and CAR-T cell therapy with sequential treatment is more effective than monotherapy [6].

Core Viewpoint - Coffee is one of the most popular beverages globally, with 80% of adults consuming at least one caffeinated drink daily, leading to an estimated consumption of 3 billion cups of coffee each day. Recent studies have shifted the perception of coffee from potentially harmful to beneficial, highlighting various health benefits associated with regular coffee consumption, including reduced all-cause mortality and lower risks of several diseases [3][4]. Group 1 - A recent study published in Scientific Reports indicates that regular caffeine consumers experience improved mood after consuming caffeinated beverages, with the effect being more pronounced in the morning [4][6]. - The study involved 236 young participants over four weeks, who reported their emotions and caffeine intake via smartphone surveys, focusing on real-life caffeine consumption rather than controlled lab settings [6][7]. - Results showed a significant correlation between caffeine intake and increased positive emotions, particularly within the first 2.5 hours after waking up, while the relationship with reduced negative emotions was weaker and consistent across different demographic groups [6][7]. Group 2 - Researchers attribute the mood-enhancing effects of caffeine in the morning to its ability to block adenosine receptors, promoting alertness and vitality, and increasing dopamine activity in key brain areas associated with improved mood and alertness [7]. - The authors of the study caution that caffeine can lead to dependence and excessive intake may pose health risks, particularly if consumed in the evening, which could disrupt sleep [8].

Core Viewpoint - The study highlights the enhanced formation of tertiary lymphoid structures (TLS) after FOLFOX-HAIC therapy, which shapes the anti-tumor microenvironment in hepatocellular carcinoma (HCC) [4][10]. Group 1: Research Findings - HCC is a common malignant tumor globally and the third leading cause of cancer-related deaths, with advanced HCC having poor prognosis and limited treatment options [6]. - The FOLFOX-HAIC treatment significantly improves survival rates in HCC patients, with disease remission rates ranging from 25% to 46% [6]. - The study demonstrates that FOLFOX-HAIC therapy significantly promotes the formation of TLS in HCC tissues, correlating with improved treatment outcomes and prolonged progression-free survival [6][8]. Group 2: Mechanisms of Action - HAIC induces central memory T cell-like CD4+ T cells expressing lymphotoxin-β (LTβ), which activate MMP2+ fibroblasts and FOLR2+ CCL4+ macrophages through the LTβ-LTβR signaling axis, driving TLS formation [7]. - The CXCL12-CXCR4 signaling axis plays a crucial mediating role in recruiting these cells to tumors treated with HAIC, enhancing TLS formation and anti-tumor immune response [7][8]. Group 3: Clinical Implications - The presence of TLS within tumors can predict better efficacy and prognosis for HCC patients undergoing HAIC [8]. - The collaboration between TCM-like CD4+ T cells, fibroblasts, and macrophages is essential for inducing TLS formation [8]. - The findings underscore the critical role of tumor-infiltrating lymphocytes in HAIC-induced anti-tumor immunity and their potential as reliable prognostic biomarkers, providing therapeutic targets for optimizing clinical outcomes in HCC patients [10].

Core Viewpoint - The research led by Professor Tao Wei from Harvard Medical School demonstrates that IL-10-mRNA nanoparticles can significantly enhance cancer immunotherapy effectiveness and induce lasting anti-tumor immune memory, effectively preventing cancer recurrence [2][3][5]. Group 1: Research Findings - The study confirms that intravenous injection of IL-10-mRNA nanoparticles triggers strong immune surveillance in various preclinical tumor models while reducing systemic toxicity [4]. - IL-10-mRNA nanoparticles maintain local IL-10 production, promoting extensive infiltration and proliferation of cytotoxic T cells, activation and maturation of dendritic cells, and upregulation of MHC-I molecules in immunosuppressive early-stage liver cancer [5]. - In a model of advanced liver cancer, the combination of IL-10-mRNA nanoparticles and immune checkpoint blockade therapy achieved complete tumor clearance in 43% of mice, extending median survival sixfold compared to the immune checkpoint blockade alone, and providing 100% protection against tumor reattack [5][7]. Group 2: Implications for Treatment - The strategy of intravenous injection of IL-10-mRNA nanoparticles is expected to overcome the limitations faced by recombinant IL-10 in clinical trials for various immunosuppressive tumors [7].

Core Viewpoint - The study reveals the complex interactions between neurons and glioblastoma cells, highlighting long-range cholinergic input as a significant factor in glioblastoma progression, providing new insights for cancer neuroscience research [4][8]. Group 1: Research Findings - The research team created a comprehensive brain connectivity map of glioblastoma (GBM) cells, demonstrating the influence of long-range cholinergic neurons on GBM progression [4][9]. - Local inputs are primarily glutamatergic, while long-distance connections exhibit diverse neurotransmitter characteristics, with cholinergic projections from the basal forebrain being a conserved input across different regions [7][9]. - The study identifies that acetylcholine release through muscarinic receptor CHRM3 promotes GBM growth in a circuit-specific manner, and blocking both acetylcholine and glutamate pathways results in an additive anti-tumor effect [10] [9]. Group 2: Implications for Treatment - Anticholinergic drug scopolamine inhibits GBM growth, while acetylcholinesterase inhibitor donepezil exacerbates the condition, indicating the potential for targeted therapies based on neurotransmitter signaling [4][7]. - The findings suggest that long-range neural regulatory pathways could serve as promising therapeutic targets for glioblastoma treatment [8].

Core Viewpoint - The research presents a novel RNA editing tool, R-IscB, engineered from the Cas9 ancestor IscB, which offers a safer and more efficient alternative to existing RNA editing technologies like Cas13, addressing the limitations of current methods in clinical applications [3][4][16]. Group 1: RNA Editing Technology - CRISPR-Cas9 has revolutionized genome medicine but poses irreversible DNA editing risks, limiting its clinical use [3]. - RNA editing is a safer alternative due to its transient and reversible nature, but existing tools like CRISPR-Cas13 face significant challenges, including off-target effects and cellular toxicity [3][4]. - The study by Yale University transformed IscB and Cas9 into RNA-guided RNA editors, demonstrating potential applications in splice interference, trans-splicing, and RNA base editing [4][16]. Group 2: Engineering and Mechanism - The research team engineered IscB by removing its TID/PID domains, converting it into R-IscB, which retains the ability to recognize single-stranded DNA/RNA while losing its double-stranded DNA cutting capability [8][14]. - R-IscB exhibits a strong affinity for single-stranded RNA, surpassing Cas13 in performance [8][12]. Group 3: Applications and Efficacy - R-IscB has shown effectiveness in various applications: 1. RNA splicing regulation, significantly reducing pathogenic mRNA levels [10]. 2. Trans-splicing capabilities to correct mutations in mRNA, potentially simplifying treatments for complex genetic disorders [11]. 3. RNA base editing for precise single nucleotide changes, useful for correcting disease-causing mutations [11]. 4. RNA degradation through enhanced cutting activity, effectively lowering target mRNA levels [11]. Group 4: Advantages Over Cas13 - R-IscB presents several disruptive advantages compared to Cas13: 1. Zero toxicity, with no observed cell death or morphological abnormalities in treated cells [13]. 2. Superior activity in splicing regulation and RNA cutting [13]. 3. Smaller size, facilitating easier delivery via AAV viral vectors for in vivo RNA editing [13]. 4. Versatility, as the same engineering strategy successfully enhanced RNA editing capabilities in multiple Cas9 variants [13][14].

Core Viewpoint - The research conducted by Wang Jiawei's team at the Chinese Academy of Sciences has made significant advancements in plant developmental biology by creating a unified cell atlas of vascular plants, which enhances gene discovery and addresses the challenges of gene redundancy in forward genetics [5][6]. Group 1: Research Breakthroughs - The study published in the journal Cell presents the world's first integrated cell atlas of vascular plants, identifying foundational genes for various cell types, thus overcoming bottlenecks in efficient gene discovery [5][6]. - The research team constructed a shoot apex single-cell atlas across six representative species, revealing the foundational gene framework for key plant cell types, significantly improving gene function exploration efficiency [6][7]. Group 2: Methodological Innovations - The team developed an automated cell classification algorithm tool for vascular plant cell types, accelerating the analysis and application of single-cell data [7][10]. - By comparing cross-species single-cell transcriptome maps, the team identified core gene modules for conserved cell types, enabling precise candidate gene screening and avoiding redundancy from random mutations [6][10]. Group 3: New Discoveries - The research identified novel regulatory factors and cell types, including previously unrecognized X8 domain proteins and JULGI-LIKE proteins, which are regulatory factors for phloem development [6][10]. - The study also recognized a new cell type, companion cell-like cells, in ferns and gymnosperms, expanding the understanding of plant cell diversity [6].

Core Viewpoint - The establishment of the Life Sciences Open Alliance aims to enhance international collaboration in talent cultivation, innovative research, resource sharing, and multi-modal transformation in the life sciences sector [3]. Group 1: Alliance Formation - The Life Sciences Open Alliance was launched on August 12, 2025, involving nine high-level universities and research institutions from mainland China and six universities from Hong Kong and Macau [3]. - The initial focus of the alliance will be on high-level international journals, research data sharing platforms, and biological resource repositories [3]. Group 2: Journal Development - West Lake University has initiated a new journal named "Vita," which will adopt an open access model and aims to become a leading international academic journal in the life sciences [6]. - The journal "Vita" will be led by prominent figures in the field, including the former editor-in-chief of "Cell Research," Li Dangsheng, and the president of West Lake University, Shi Yigong [3][6]. Group 3: Academic Publishing Landscape - China has surpassed the United States in the total number of published papers, ranking second in high-level papers globally [6]. - Despite the increase in domestic publications, many researchers still prefer to publish in internationally recognized journals like Nature, Science, and Cell due to the limited number of influential domestic journals [6]. - "Cell Research," founded in 1990, has evolved significantly, achieving an impact factor of over 20 by 2020, making it one of the most influential life sciences journals in Asia [9].